Position in BCRX
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$122,890
-$154,511 QoQ
Shares Held
12,289
-38.6% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#240
of 316 holders
Holding Since
Dec 2021
2 quarters on record
Voting authority
Sole 84%
Shared 0%
None 16%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Ethic Inc. holds $15,329,079 across 10 Drug Manufacturers - Specialty & Generic names. BCRX ranks #10 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TAK |
Takeda Pharmaceutical Co Ltd
|
365,253 | $5,855,005 | |
| 2 | ZTS |
Zoetis Inc.
|
40,796 | $2,931,600 | |
| 3 | RDY |
Dr Reddys Laboratories Ltd
|
132,074 | $1,913,752 | |
| 4 | HLN |
Haleon plc
|
109,770 | $1,024,154 | |
| 5 | VTRS |
Viatris Inc
|
53,626 | $851,580 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
1,539 | $833,876 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
33,453 | $823,278 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
20,171 | $683,393 |
All Filings in BCRX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $122,890 | 12,289 | Shares | Sole | 2026-07-29 | |
| 2021-12-31 | $277,401 | 20,029 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||